Imricor Medical Systems, Inc. (ASX:IMR)
Australia · Delayed Price · Currency is AUD 1.970
+0.040 (2.07%)
Aug 28, 2026, 4:10 PM AEST
Imricor Medical Systems Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.12 | 0.29 | 0.96 | 0.62 | 0.82 | 0.7 | |
Revenue Growth | -83.96% | -69.53% | 55.86% | -24.56% | 17.20% | -0.84% |
Cost of Revenue | 2.91 | 2.33 | 1.88 | 1.73 | 2.34 | 2.59 |
Gross Profit | -2.79 | -2.03 | -0.92 | -1.12 | -1.53 | -1.9 |
Selling, General & Admin | 11.5 | 9.6 | 7.19 | 7.82 | 7.79 | 8.69 |
Research & Development | 13.13 | 11.16 | 8.18 | 7.92 | 7.95 | 9.68 |
Operating Expenses | 24.63 | 20.76 | 15.37 | 15.74 | 15.73 | 18.36 |
Operating Income | -27.41 | -22.79 | -16.3 | -16.86 | -17.26 | -20.26 |
Interest Expense | - | -0 | -0.02 | -0.05 | -0.18 | -0.11 |
Interest & Investment Income | 1.34 | 1.18 | 0.26 | 0.06 | 0.11 | 0.02 |
Currency Exchange Gain (Loss) | 0.07 | 1.51 | 0.2 | 0.01 | -0.02 | -0.04 |
Other Non Operating Income (Expenses) | -1.89 | -0.07 | -2.42 | -5.79 | -0.01 | -0.1 |
EBT Excluding Unusual Items | -27.89 | -20.17 | -18.28 | -22.63 | -17.36 | -20.49 |
Other Unusual Items | -9.42 | -5.14 | -11.42 | - | - | 0.76 |
Pretax Income | -37.32 | -25.32 | -29.69 | -22.63 | -17.36 | -19.73 |
Net Income | -37.32 | -25.32 | -29.69 | -22.63 | -17.36 | -19.73 |
Net Income to Common | -37.32 | -25.32 | -29.69 | -22.63 | -17.36 | -19.73 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 326 | 309 | 224 | 157 | 146 | 131 |
Shares Outstanding (Diluted) | 326 | 309 | 224 | 157 | 146 | 131 |
Shares Change | 17.63% | 37.84% | 43.03% | 7.46% | 11.42% | 18.76% |
EPS (Basic) | -0.11 | -0.08 | -0.13 | -0.14 | -0.12 | -0.15 |
EPS (Diluted) | -0.12 | -0.08 | -0.13 | -0.14 | -0.12 | -0.15 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -24.79 | -19.52 | -15.65 | -13.06 | -16.75 | -18.11 |
Free Cash Flow Per Share | -0.08 | -0.06 | -0.07 | -0.08 | -0.12 | -0.14 |
Gross Margin | - | - | -96.32% | -181.27% | -187.10% | -272.30% |
Operating Margin | -22830.48% | -7796.87% | -1698.60% | -2738.12% | -2115.18% | -2909.72% |
Profit Margin | -31076.71% | -8661.58% | -3094.86% | -3675.61% | -2126.96% | -2834.05% |
Free Cash Flow Margin | -20647.92% | -6676.31% | -1631.38% | -2121.66% | -2052.56% | -2601.63% |
EBITDA | -26.65 | -21.99 | -15.55 | -16.15 | -16.55 | -19.57 |
D&A For EBITDA | 0.76 | 0.8 | 0.75 | 0.71 | 0.71 | 0.69 |
EBIT | -27.41 | -22.79 | -16.3 | -16.86 | -17.26 | -20.26 |
Revenue as Reported | 0.29 | 0.29 | 0.96 | 0.62 | 0.82 | 0.7 |